MARKET COMPOSITE
PODD - Insulet Corporation8:00:00 PM 3/28/2024
Price
$171.40
+ 2.22 (1.31%)
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Its Omnipod System comprise two devices: a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, and its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, and the Middle East. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.
Financials
Quarterly financials
(USD)Dec 2022Q/Q
Revenue282.6MM+0%
Gross Profit217.3MM+15%
Cost Of Revenue152.4MM-0%
Operating Income23.5MM-
Operating Expenses193.8MM-
Net Income17MM-427%
R&D49.5MM+10%
Marketing--
Amortization1.8MM-5%
Interest Expense9.2MM-
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news

    The consensus price target hints at a 38.9% upside potential for Insulet (PODD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

    What are the early trends we should look for to identify a stock that could multiply in value over the long term...

    Twilio, Zscaler, NextEra Energy, and American Water Works are part of the Zacks top Analyst Blog.

    We have narrowed our search to five large-cap stocks with attractive valuations. These are TWLO, ZS, NEE, AWK and PODD.

    After an abysmal 2023, healthcare stocks are nearly keeping pace with the broader market this year. The fund, which tracks healthcare stocks in the has returned 7.3% so far this year as of Tuesday’s market close—just a bit behind the broader index, which has returned 8.9%. Healthcare stocks fell deeply out of favor in 2023, amid a rush away from what had been thought of as defensive plays into hot tech stocks.

    Three S&P 500 stocks worth considering as buy-and-hold investments that are down at least 30% from their highs even as the market trades at records.

    Chadwick succeeds Wayde McMillan, who left last year to become CFO for 3M’s health spinoff.

    In this article, we discuss the 10 NASDAQ stocks with the biggest upside. To skip our detailed analysis, go directly to the 5 NASDAQ Stocks with Biggest Upside. The Nasdaq Composite was the worst performer among the major market indices in 2022 and made a stellar comeback in 2023. The index was down 33% at […]

    ACTON, Mass., March 20, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Ana Maria Chadwick has been appointed Executive Vice President, Chief Financial Officer and Treasurer, effective April 22, 2024. Today’s announcement concludes an extensive search process conducted by the Company.

    ClearBridge Investments, an investment management firm, released its fourth-quarter 2023 “ClearBridge Aggressive Growth Strategy” investor letter, which can be downloaded here. The strategy outperformed its Russell 3000 Growth Index benchmark for the quarter. It had delivered gains across seven of the eight sectors in which it was invested on an absolute basis. Overall stock selection contributed […]